OKYO Pharma (OKYO) Short Interest Ratio & Short Volume $1.86 +0.21 (+12.42%) As of 02:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OKYO Pharma Short Interest DataOKYO Pharma (OKYO) has a short interest of 182,100 shares, representing 0.74% of the float (the number of shares available for trading by the public). This marks a 18.48% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 120,996 shares to cover all short positions.Current Short Interest182,100 sharesPrevious Short Interest153,700 sharesChange Vs. Previous Month+18.48%Dollar Volume Sold Short$288,628.50Short Interest Ratio1.6 Days to CoverLast Record DateApril 30, 2025Outstanding Shares33,836,000 sharesFloat Size24,540,000 sharesShort Percent of Float0.74%Today's Trading Volume105,610 sharesAverage Trading Volume120,996 sharesToday's Volume Vs. Average87% Short Selling OKYO Pharma? Sign up to receive the latest short interest report for OKYO Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOKYO Short Interest Over TimeOKYO Days to Cover Over TimeOKYO Percentage of Float Shorted Over Time OKYO Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025182,100 shares $288,628.50 +18.5%0.7%1.6 $1.59 4/15/2025153,700 shares $172,144.00 -14.2%0.6%0.9 $1.12 3/31/2025179,200 shares $227,584.00 -17.8%0.7%1 $1.27 3/15/2025217,900 shares $328,767.52 -35.5%0.9%1.2 $1.51 2/28/2025338,000 shares $425,846.20 +30.4%1.4%2.2 $1.26 2/15/2025259,200 shares $283,824.00 -22.1%1.1%2 $1.10 1/31/2025332,800 shares $352,768.00 +59.8%1.4%2.7 $1.06 1/15/2025208,300 shares $210,383.00 -3.9%0.9%2.6 $1.01 12/31/2024216,800 shares $249,298.32 +0.5%0.9%2.8 $1.15 12/15/2024215,800 shares $228,748.00 -12.2%0.9%3.9 $1.06 Get the Latest News and Ratings for OKYO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OKYO Pharma and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024245,700 shares $250,859.70 +4.9%1.0%4.4 $1.02 11/15/2024234,300 shares $250,701.00 -13.9%1.0%3.1 $1.07 10/31/2024272,000 shares $320,960.00 +46.6%1.1%1.4 $1.18 10/15/2024185,500 shares $189,210.00 -11.5%0.8%0.9 $1.02 9/30/2024209,700 shares $213,894.00 -5.9%0.9%1.1 $1.02 9/15/2024222,800 shares $229,484.00 -10.7%0.9%1.2 $1.03 8/31/2024249,400 shares $299,280.00 +278.5%1.0%1.3 $1.20 8/15/202465,900 shares $64,588.59 +45.2%0.3%0.4 $0.98 7/31/202445,400 shares $55,842.00 -6.0%0.2%1.1 $1.23 7/15/202448,300 shares $76,797.00 +21.7%0.2%2.2 $1.59 6/30/202439,700 shares $47,243.00 -6.6%0.2%2.4 $1.19 6/15/202442,500 shares $55,594.25 -6.0%0.2%1.8 $1.31 5/31/202445,200 shares $67,348.00 -28.6%0.3%0.7 $1.49 5/15/202463,300 shares $94,317.00 -20.4%0.3%0.9 $1.49 4/30/202479,500 shares $119,250.00 -14.1%0.4%0.5 $1.50 4/15/202492,500 shares $124,875.00 -49.3%0.5%0.6 $1.35 3/31/2024182,500 shares $271,925.00 +259.3%1.0%1 $1.49 3/15/202450,800 shares $75,692.00 -21.4%0.3%0.3 $1.49 2/29/202464,600 shares $85,918.00 -39.6%0.4%0.4 $1.33 2/15/2024106,900 shares $150,729.00 +108.8%0.6%0.8 $1.41 1/31/202451,200 shares $75,264.00 -30.0%0.3%0.4 $1.47 1/15/202473,100 shares $126,463.00 +54.2%0.4%1.4 $1.73 12/31/202347,400 shares $83,898.00 -0.6%0.3%0.7 $1.77 12/15/202347,700 shares $83,475.00 -37.7%0.3%0.4 $1.75 11/30/202376,600 shares $128,688.00 -1.9%0.5%0.6 $1.68 11/15/202378,100 shares $130,427.00 No Change0.5%0.3 $1.67 10/31/202378,100 shares $127,303.00 -35.6%0.5%0.3 $1.63 10/15/2023121,200 shares $203,616.00 +40.1%0.7%0.4 $1.68 9/30/202386,500 shares $160,025.00 -40.8%0.5%0.3 $1.85 9/15/2023146,000 shares $289,080.00 -48.3%0.9%0.6 $1.98AI Meltdown Imminent: Dump These Stocks Now! (Ad)If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.Click here to see the details and learn how to prepare for the next AI revolution 8/31/2023282,400 shares $567,624.00 +132.2%1.1%1.2 $2.01 8/15/2023121,600 shares $200,640.00 +157.1%0.5%1.1 $1.65 7/31/202347,300 shares $88,451.00 +23.5%0.2%0.3 $1.87 7/15/202338,300 shares $44,807.17 -18.0%0.2%0.4 $1.17 6/30/202346,700 shares $53,238.00 -30.0%0.2%0.5 $1.14 6/15/202366,700 shares $86,376.50 +1.2%0.3%0.7 $1.30 5/31/202365,900 shares $102,804.00 -22.8%0.3%0.3 $1.56 5/15/202385,400 shares $137,494.00 No ChangeN/A0 $1.61 7/15/2022100 shares $214.00 No ChangeN/A0 $2.14 OKYO Short Interest - Frequently Asked Questions What is OKYO Pharma's current short interest? Short interest is the volume of OKYO Pharma shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 182,100 shares of OKYO short. 0.74% of OKYO Pharma's shares are currently sold short. Learn More on OKYO Pharma's current short interest. What is a good short interest ratio for OKYO Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OKYO shares currently have a short interest ratio of 2.0. Learn More on OKYO Pharma's short interest ratio. What is a good short interest percentage for OKYO Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.74% of OKYO Pharma's floating shares are currently sold short. Is OKYO Pharma's short interest increasing or decreasing? OKYO Pharma saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 182,100 shares, an increase of 18.5% from the previous total of 153,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is OKYO Pharma's float size? OKYO Pharma currently has issued a total of 33,836,000 shares. Some of OKYO Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. OKYO Pharma currently has a public float of 24,540,000 shares. How does OKYO Pharma's short interest compare to its competitors? 0.74% of OKYO Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to OKYO Pharma: MediWound Ltd. (14.07%), Bright Minds Biosciences Inc. (1.77%), Tevogen Bio Holdings Inc. (11.98%), enGene Holdings Inc. (0.31%), Solid Biosciences Inc. (11.01%), Aerovate Therapeutics, Inc. (21.72%), Genfit S.A. (0.14%), ADC Therapeutics SA (4.51%), Kodiak Sciences Inc. (7.42%), Design Therapeutics, Inc. (11.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short OKYO Pharma stock? Short selling OKYO is an investing strategy that aims to generate trading profit from OKYO Pharma as its price is falling. OKYO shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against OKYO Pharma? A short squeeze for OKYO Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OKYO, which in turn drives the price of the stock up even further. How often is OKYO Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OKYO, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies MDWD Short Interest Data DRUG Short Interest Data TVGN Short Interest Data ENGN Short Interest Data SLDB Short Interest Data AVTE Short Interest Data GNFT Short Interest Data ADCT Short Interest Data KOD Short Interest Data DSGN Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OKYO) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OKYO Pharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share OKYO Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.